|
[]article
Volume 270,
Number 37,
Issue of September 15, pp. 22058-22065, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Purification
of a Novel Protein (ps20) from Urogenital Sinus Mesenchymal Cells with
Growth Inhibitory Properties in Vitro
(Received for publication, June 19, 1995; and in revised form, July 11, 1995)
David R.
Rowley
, <WBR>
Truong D.
Dang,
Melinda
Larsen
, <WBR>
Michael J.
Gerdes,
Lauren
McBride ,
Bing
Lu
Our previous studies have characterized mesenchyme-derived
proteins to identify biologically active proteins and novel markers for
stromal cell paracrine action relative to stromal-epithelial
interactions. Previous reports have characterized properties of a
growth inhibitory activity (to bladder and prostatic epithelial cells),
secreted by U4F fetal rat urogenital sinus mesenchymal cells, not
cross-reactive with antibodies to known cytokines, and provisionally
termed UGIF. The present study reports the characterization,
purification, and biological properties of a 20-21-kDa protein
responsible for UGIF activity. The 20-21-kDa protein (termed
ps20) was purified to near homogeneity, the amino-terminal sequence was
determined, and biological properties were characterized in
vitro. Amino-terminal sequence analysis indicated no direct
matches or regions of homology with known proteins. Purified ps20
induced a linear and saturable inhibition of
thymidine incorporation in PC-3 prostatic
carcinoma cells (half-maximal activity at 2.6 nM), inhibited
cell proliferation (increased population doubling time from 19.8 to
25.8 h), and induced a 210% stimulation in the synthesis of secreted
proteins. These data suggest that ps20 may be a candidate paracrine
effector protein and may play a role in stromal-epithelial cell
interactions in the prostate gland.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Madar, R. Brosh, Y. Buganim, O. Ezra, I. Goldstein, H. Solomon, I. Kogan, N. Goldfinger, H. Klocker, and V. Rotter
Modulated expression of WFDC1 during carcinogenesis and cellular senescence
Carcinogenesis,
January 1, 2009;
30(1):
20 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Alvarez, J. Reading, D. F. L. King, M. Hayes, P. Easterbrook, F. Farzaneh, S. Ressler, F. Yang, D. Rowley, and A. Vyakarnam
WFDC1/ps20 Is a Novel Innate Immunomodulatory Signature Protein of Human Immunodeficiency Virus (HIV)-Permissive CD4+ CD45RO+ Memory T Cells That Promotes Infection by Upregulating CD54 Integrin Expression and Is Elevated in HIV Type 1 Infection
J. Virol.,
January 1, 2008;
82(1):
471 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. McAlhany, S. J. Ressler, M. Larsen, J. A. Tuxhorn, F. Yang, T. D. Dang, and D. R. Rowley
Promotion of Angiogenesis by ps20 in the Differential Reactive Stroma Prostate Cancer Xenograft Model
Cancer Res.,
September 15, 2003;
63(18):
5859 - 5865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gerdes, T. D. Dang, M. Larsen, and D. R. Rowley
Transforming Growth Factor-{beta}1 Induces Nuclear to Cytoplasmic Distribution of Androgen Receptor and Inhibits Androgen Response in Prostate Smooth Muscle Cells
Endocrinology,
August 1, 1998;
139(8):
3569 - 3577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Larsen, S. J. Ressler, B. Lu, M. J. Gerdes, L. McBride, T. D. Dang, and D. R. Rowley
Molecular Cloning and Expression of ps20 Growth Inhibitor. A NOVEL WAP-TYPE "FOUR-DISULFIDE CORE" DOMAIN PROTEIN EXPRESSED IN SMOOTH MUSCLE
J. Biol. Chem.,
February 20, 1998;
273(8):
4574 - 4584.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|